Study aid only. Verify against current guidelines, primary literature, staging manuals, and prescribing information before clinical use.

← All algorithms  ·  Related notes →

Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (often EBV-associated) Early T1 N0 Definitive RT alone Locally advanced T2–4 and/or N+ Concurrent cisplatin + RT → adjuvant chemo Induction gem/cisplatin → concurrent chemoRT EBV-associated Recurrent / metastatic Gem/cisplatin + toripalimab JUPITER-02 (first line) ↗ Gem/cisplatin ± other PD-1 camrelizumab (CAPTAIN-1st) / penpulimab ↗ Toripalimab subsequent line (post-platinum)